查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600533

醫用生物聚合物市場：按類型、來源、應用分類 - 2025-2030 年全球預測

Biopolymers for Medical Applications Market by Type (Bio-Based Polyethylene, Bio-degradable Starch Blends, Bio-PC), Source (Natural, Synthetic), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年醫用生物聚合物市場價值為24.3億美元，預計到2024年將達到30億美元，複合年成長率為23.24%，預計到2030年將達到105.2億美元。

醫用生物聚合物包括因其生物相容性、生物分解性和低毒性而用於各種醫療環境的天然衍生聚合物。這些材料在醫療設備、組織工程、傷口敷料、藥物傳遞系統等方面發揮重要作用。由於對永續和環保醫療產品的需求不斷增加，加上生物技術的進步，醫療領域對生物聚合物的需求不斷成長。應用範圍廣泛，包括外科植入、藥物傳輸系統和組織工程支架，最終用途為醫院、研究機構和專科診所。關鍵的成長要素包括慢性病盛行率的增加、永續實踐意識的增強以及醫療應用的技術進步。此外，有利於生物基產品的法規環境正在增加市場機會。一個值得注意的機會在於使用基於生物聚合物的載體開發個人化醫療解決方案，以提供副作用最小的創新治療方法。然而，高製造成本、有限的機械性能和嚴格的監管要求等挑戰構成了市場成長的主要障礙。透過改善生物聚合物混合物的性能、改進生產過程以降低成本以及擴大在不太飽和的市場（例如生物分解性的整形外科植入）中的應用，可以加速創新。需要進一步研究開發具有更好機械和熱性能的生物聚合物，以確保更廣泛的適用性。生物聚合物市場的本質是動態的，受到不斷的技術進步和不斷成長的最終用戶需求的推動，凸顯了持續投資研發的必要性。希望利用這個快速成長市場的公司正在專注於與生物技術公司建立策略夥伴關係關係，以瞄準未開發的區域市場，最大限度地提高成長潛力並促進業務擴張。

主要市場統計
基準年[2023] 24.3億美元
預測年份 [2024] 30億美元
預測年份 [2030] 105.2億美元
複合年成長率（%） 23.24%

市場動態：揭示快速發展的醫用生物聚合物市場的關鍵市場洞察

供需的動態交互作用正在改變醫用生物聚合物市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 醫療設備和植入製造對生物聚合物的需求增加
    • 擴大生物聚合物在先進影像和骨骼組織特異性治療的應用
    • 生物高分子滅菌技術的開發
  • 市場限制因素
    • 生物聚合物性能問題
  • 市場機會
    • 生物聚合物創新與永續生產
    • 奈米顆粒藥物傳輸系統在癌症中的普及
  • 市場挑戰
    • 與合成生物聚合物相關的生物相容性問題

波特五力：駕馭醫用生物聚合物市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解對醫用生物聚合物市場的外部影響

外部宏觀環境因素在塑造醫用生物聚合物市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解醫用生物聚合物市場的競爭格局

對醫用生物聚合物市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣醫用生物聚合物市場供應商的績效評估

FPNV定位矩陣是評估醫用生物聚合物市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 醫療設備和植入製造對生物聚合物的需求增加
      • 擴大生物聚合物在先進影像和骨骼組織特異性治療的應用
      • 生物高分子滅菌技術的開發
    • 抑制因素
      • 與生物聚合物相關的性能問題
    • 機會
      • 生物聚合物創新與永續生產
      • 奈米顆粒藥物傳輸系統在癌症中的普及
    • 任務
      • 與合成生物聚合物相關的生物相容性問題
  • 市場區隔分析
    • 類型：永續性發展的趨勢集中在生物聚合物的醫療保健應用
    • 資料來源：由於生物相容性、生物功能性、機械性質、分解率和免疫抗原性的改善，合成生物聚合物的需求不斷增加。
    • 應用：改良的組織生成能力擴大了在傷口傷口縫合和癒合、創傷治療等方面的應用。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境
  • 客戶客製化
    • 專利分析及趨勢

第6章醫用生物聚合物市場：依類型

  • 生物基聚乙烯
  • 生物分解性澱粉混合物
  • 生物電腦
  • Bio-Pet
  • 生物聚氨酯
  • 纖維素衍生物
  • Pha
  • 再生纖維素

第7章醫用生物聚合物市場：依來源分類

  • 自然的
  • 合成

第8章醫用生物聚合物市場：依應用分類

  • 生物可吸收支架
  • 牙科
  • 藥物輸送系統。
  • 治療產品
  • 手術植入裝置
  • 治療影像
  • 傷口縫合

第9章美洲醫用生物聚合物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太醫用生物聚合物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲醫用生物聚合物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 杜邦完成對頻譜 Plastics Group 的收購
    • 賽諾菲完成對 Prevention Bio, Inc. 的收購
    • 威格斯投資新的醫療設備產品開發中心和製造擴張

公司名單

  • Geistlich Pharma AG
  • Blafar Ltd.
  • GELITA AG
  • BioPolymer GmbH & Co. KG
  • Green Dot Bioplastics Inc.
  • Corbion NV
  • Evonik Industries AG
  • ITV Denkendorf Product Service GmbH
  • Thermo Fisher Scientific, Inc.
  • Danimer Scientific, Inc.
  • Toray Industries Inc.
  • Symatese
  • HyMedPoly
  • BASF SE
  • Merck & Co., Inc.
  • Tate & Lyle PLC
  • Biesterfeld AG
  • Invibio Ltd. by Victrex PLC
  • Solvay SA
  • NatureWorks LLC
  • Rodenburg Productie BV
  • SolyPlus GmbH
  • Eastman Chemical Company
  • HTL
  • DuPont de Nemours, Inc.
Product Code: MRR-435FD7709B83

The Biopolymers for Medical Applications Market was valued at USD 2.43 billion in 2023, expected to reach USD 3.00 billion in 2024, and is projected to grow at a CAGR of 23.24%, to USD 10.52 billion by 2030.

Biopolymers for medical applications encompass naturally derived polymers used in various medical settings due to their biocompatibility, biodegradable properties, and low toxicity. These materials play an essential role in medical devices, tissue engineering, wound dressing, drug delivery systems, and more. The rising necessity for biopolymers in the medical field is driven by an increasing demand for sustainable and eco-friendly medical products coupled with advances in biotechnology. Applications extend across surgical implants, drug delivery systems, and scaffolding materials for tissue engineering, while their end-use spans hospitals, research facilities, and specialized clinics. Key growth factors include the increasing prevalence of chronic diseases, heightened awareness of sustainable practices, and technological advancements in medical applications. Furthermore, the regulatory environment favoring bio-based products enhances market opportunities. A notable opportunity lies in the development of personalized medicine solutions utilizing biopolymer-based carriers for active ingredients, offering innovative treatment paths with minimized side effects. However, challenges such as high production costs, limited mechanical properties, and strict regulatory requirements pose significant barriers to market growth. Innovation can be fostered by improving biopolymer blend properties, enhancing production processes to reduce costs, and expanding applications in less saturated markets such as biodegradable orthopedic implants. Further research is needed to develop biopolymers with better mechanical and thermal properties ensuring broader application potential. The nature of the biopolymer market is dynamic, driven by constant technological advancements and increasing end-user demands, highlighting the need for continuous investment in research and development. Companies aiming to capitalize on this burgeoning market should focus on strategic partnerships with biotech firms and focus on targeting underdeveloped regional markets with tailored biopolymer products to maximize growth potential and foster business expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 2.43 billion
Estimated Year [2024] USD 3.00 billion
Forecast Year [2030] USD 10.52 billion
CAGR (%) 23.24%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopolymers for Medical Applications Market

The Biopolymers for Medical Applications Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Biopolymers demand for Manufacturing of Medical Devices and Implants
    • Growing Adoption of Biopolymers for Advanced Imaging and Skeletal Tissue-Specific Therapeutics
    • Development of Sterilization Technology for Biopolymers
  • Market Restraints
    • Performance Issues Associated with the Biopolymers
  • Market Opportunities
    • Innovations and Sustainable Production of Biopolymers
    • Proliferation of Nano-Particle Drug Delivery Systems in Cancer
  • Market Challenges
    • Biocompatibility Issues Associated with Synthetic Biopolymers

Porter's Five Forces: A Strategic Tool for Navigating the Biopolymers for Medical Applications Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopolymers for Medical Applications Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopolymers for Medical Applications Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopolymers for Medical Applications Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopolymers for Medical Applications Market

A detailed market share analysis in the Biopolymers for Medical Applications Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopolymers for Medical Applications Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopolymers for Medical Applications Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Biopolymers for Medical Applications Market, highlighting leading vendors and their innovative profiles. These include Geistlich Pharma AG, Blafar Ltd., GELITA AG, BioPolymer GmbH & Co. KG, Green Dot Bioplastics Inc., Corbion NV, Evonik Industries AG, ITV Denkendorf Product Service GmbH, Thermo Fisher Scientific, Inc., Danimer Scientific, Inc., Toray Industries Inc., Symatese, HyMedPoly, BASF SE, Merck & Co., Inc., Tate & Lyle PLC, Biesterfeld AG, Invibio Ltd. by Victrex PLC, Solvay S.A., NatureWorks LLC, Rodenburg Productie B.V., SolyPlus GmbH, Eastman Chemical Company, HTL, and DuPont de Nemours, Inc..

Market Segmentation & Coverage

This research report categorizes the Biopolymers for Medical Applications Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Bio-Based Polyethylene, Bio-degradable Starch Blends, Bio-PC, Bio-PET, Bio-PUR, Cellulose Derivatives, PHA, and Regenerated Cellulose.
  • Based on Source, market is studied across Natural and Synthetic.
  • Based on Application, market is studied across Bioresorbable Scaffolds, Dentistry, Drug Delivery Systems., Healing Products, Surgical Implant Devices, Therapeutic Imaging, and Wound Closure.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Biopolymers demand for Manufacturing of Medical Devices and Implants
      • 5.1.1.2. Growing Adoption of Biopolymers for Advanced Imaging and Skeletal Tissue-Specific Therapeutics
      • 5.1.1.3. Development of Sterilization Technology for Biopolymers
    • 5.1.2. Restraints
      • 5.1.2.1. Performance Issues Associated with the Biopolymers
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations and Sustainable Production of Biopolymers
      • 5.1.3.2. Proliferation of Nano-Particle Drug Delivery Systems in Cancer
    • 5.1.4. Challenges
      • 5.1.4.1. Biocompatibility Issues Associated with Synthetic Biopolymers
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Rising inclination toward the sustainability is emphasizing focus on application of biopolymers healthcare
    • 5.2.2. Source: Synthetic biopolymers are in demand due to enhanced biocompatibility, biofunctionality, mechanical properties, degradation rates, and immunogenicity
    • 5.2.3. Application: Expandable use in drug discovery, and wound closure owing to the rising tissue generation capability
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization
    • 5.5.1. Patent Analysis & Trend

6. Biopolymers for Medical Applications Market, by Type

  • 6.1. Introduction
  • 6.2. Bio-Based Polyethylene
  • 6.3. Bio-degradable Starch Blends
  • 6.4. Bio-PC
  • 6.5. Bio-PET
  • 6.6. Bio-PUR
  • 6.7. Cellulose Derivatives
  • 6.8. PHA
  • 6.9. Regenerated Cellulose

7. Biopolymers for Medical Applications Market, by Source

  • 7.1. Introduction
  • 7.2. Natural
  • 7.3. Synthetic

8. Biopolymers for Medical Applications Market, by Application

  • 8.1. Introduction
  • 8.2. Bioresorbable Scaffolds
  • 8.3. Dentistry
  • 8.4. Drug Delivery Systems.
  • 8.5. Healing Products
  • 8.6. Surgical Implant Devices
  • 8.7. Therapeutic Imaging
  • 8.8. Wound Closure

9. Americas Biopolymers for Medical Applications Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biopolymers for Medical Applications Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biopolymers for Medical Applications Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. DuPont Completes Acquisition of Spectrum Plastics Group
    • 12.3.2. Sanofi completes acquisition of Provention Bio, Inc.
    • 12.3.3. Victrex Invests In New Medical Device Product Development Centre And Manufacturing Expansion

Companies Mentioned

  • 1. Geistlich Pharma AG
  • 2. Blafar Ltd.
  • 3. GELITA AG
  • 4. BioPolymer GmbH & Co. KG
  • 5. Green Dot Bioplastics Inc.
  • 6. Corbion NV
  • 7. Evonik Industries AG
  • 8. ITV Denkendorf Product Service GmbH
  • 9. Thermo Fisher Scientific, Inc.
  • 10. Danimer Scientific, Inc.
  • 11. Toray Industries Inc.
  • 12. Symatese
  • 13. HyMedPoly
  • 14. BASF SE
  • 15. Merck & Co., Inc.
  • 16. Tate & Lyle PLC
  • 17. Biesterfeld AG
  • 18. Invibio Ltd. by Victrex PLC
  • 19. Solvay S.A.
  • 20. NatureWorks LLC
  • 21. Rodenburg Productie B.V.
  • 22. SolyPlus GmbH
  • 23. Eastman Chemical Company
  • 24. HTL
  • 25. DuPont de Nemours, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BASED POLYETHYLENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 68. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 71. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 74. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 77. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 80. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 83. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 86. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 93. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 99. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 102. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 108. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 111. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 114. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 117. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 120. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 123. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 126. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 129. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 132. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 138. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 141. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 144. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 147. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 155. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET, FPNV POSITIONING MATRIX, 2023